J. Tae, D.-W. Hahn / Tetrahedron Letters 45 (2004) 3757–3760
3759
C.; Murphy, F.; Barluenga, S.; Ohshima, T.; Wei, H.; Xu,
J.; Gray, D. L. F.; Baudoin, O. J. Am. Chem. Soc. 2000,
122, 3830; (d) Paquette, L. A.; Duan, M.; Konetzki, I.;
Kempmann, C. J. Am. Chem. Soc. 2002, 124, 4257; (e)
Sedrani, R.; Kallen, J.; Martin Cabrejas, L. M.; Papa-
georgiou, C. D.; Senia, F.; Rohrbach, S.; Wagner, D.;
Thai, B.; Jutzi Eme, A.-M.; France, J.; Oberer, L.; Rihs,
G.; Zenke, G.; Wagner, J. J. Am. Chem. Soc. 2003, 125,
3849.
CO2Me
CO2Me
a
CbzN
BocN
CbzN
BocN
b
m
m
11a-c
10a-c
CO2Me
CO2Me
CO2Me
CO2Me
c
CbzN
BocN
CbzN
HN
m
m
3. (a) Somsak, L.; Nagy, V.; Hadady, Z.; Docsa, T.; Gergely,
P. Curr. Pharm. Des. 2003, 9, 1177; (b) Jensen, H. H.;
Jensen, A.; Hazell, R. G.; Bols, M. J. Chem. Soc., Perkin
Trans. 1 2002, 1190; (c) Jensen, H. H.; Bols, M. J. Chem.
Soc., Perkin Trans. 1 2001, 905; (d) Ernholt, B. V.;
Thomsen, I. B.; Lohse, A.; Plesner, I. W.; Jensen, K. B.;
Hazell, R. G.; Liang, X.; Jakobsen, A.; Bols, M. Chem.
Eur. J. 2000, 6, 278; (e) Bols, M.; Hazell, R.; Thomsen, I.
Chem. Eur. J. 1997, 3, 940.
12a-c
13a-c
Scheme 3. Reagents and conditions: (a) DMAD (1.2 equiv), toluene,
110 °C, 6 h; (b) DDQ (2.0 equiv), toluene, 110 °C; (c) 50% TFA–
CH2Cl2, rt, 1 h. DMAD ¼ dimethyl acetylenedicarboxylate,
DDQ ¼ 2,3-dichloro-5,6-dicyano-1,4-benzoquinone, TFA ¼ trifluoro-
acetic acid.
4. Ciufolini, M. A.; Xi, N. Chem. Soc. Rev. 1998, 27, 437.
5. (a) Hassall, C. H.; Johnson, W. H.; Theobald, C. J. J.
Chem. Soc., Perkin Trans. 1 1979, 1451; (b) Davies, C. R.;
Davies, J. S. J. Chem. Soc., Perkin Trans. 1 1976, 2390.
6. (a) Nakamura, Y.; Shin, C.-G. Chem. Lett. 1991, 1953; (b)
Schmidt, U.; Reidl, B. J. Chem. Soc., Chem. Commun.
1992, 1186; (c) Hale, K. J.; Delisser, V. M.; Manaviazar, S.
Tetrahedron Lett. 1992, 33, 7613; (d) Toya, T.; Yama-
guchi, K.; Endo, Y. Bioorg. Med. Chem. 2002, 10, 953; (e)
Aoyagi, Y.; Saitoh, Y.; Ueno, T.; Horiguchi, M.; Takeya,
K.; Williams, R. M. J. Org. Chem. 2003, 68, 6899.
7. For synthesis of medium-size cyclic 1,2-diaza compounds,
see: (a) Baccolini, G.; Munyaneza, A.; Boga, C. Tetrahe-
dron 1996, 52, 13695; (b) Rutjes, F. P. J. T.; Paz, M. M.;
Hiemstra, H.; Speckamp, W. N. Tetrahedron Lett. 1991,
32, 6629; (c) Rutjes, F. P. J. T.; Hiemstra, H.; Mooiweer,
H. H.; Speckamp, W. N. Tetrahedron Lett. 1988, 29, 6975;
(d) Overberger, C. G.; Merkel, T. F. J. Org. Chem. 1981,
46, 442; (e) Overberger, C. G.; Chi, M.-S. J. Org. Chem.
1981, 46, 303; (f) Wawzonek, S.; Stephanie, J. G. J. Org.
Chem. 1971, 36, 2467; (g) Overberger, C. G.; Hall, J. R.
J. Org. Chem. 1961, 26, 4359.
Table 3. Conversion of 10 to 13
Entry
10
Yield (%)a
12
11
13
1
10a
11a (88)
12a (82)
13a (75)
m ¼ 1
10b
2
11a (97)
11a (92)
12b (87)
12c (92)
13b (75)
13c (50)
m ¼ 2
10c
3
m ¼ 3
a Isolated yields.
bond. The enyne RCM adducts were converted to
bicyclic aromatic heterocycles by the Diels–Alder reac-
tion/oxidation sequence.
General procedures for RCM/deprotection of Boc group:
A solution of 5a (88 mg, 0.25 mmol) and Grubbs’ cata-
lyst 7 (22 mg, 0.025 mmol) in CH2Cl2 (13 mL) was ref-
luxed at 45 °C for 8 h under N2. The solvent was
removed under reduced pressure and the residue mixture
was column chromatographed on silica gel (hexane/
EtOAc ¼ 20:1) to give 75 mg (93%) of 8a. A solution of
8a in 50% TFA–CH2Cl2 (4 mL) was stirred for 1 h at
room temperature. The solvent was removed under
reduced pressure and the residue mixture was column
chromatographed on silica gel (hexane/EtOAc ¼ 5:1) to
give 49 mg (96%) of 9a.13
8. For selected recent reviews on olefin metathesis, see: (a)
Grubbs, R. H.; Chang, S. Tetrahedron 1998, 54, 4413; (b)
€
Furstner, A. Angew. Chem., Int. Ed. 2000, 39, 3012; (c)
Connon, S. J.; Blechert, S. Angew. Chem., Int. Ed. 2003,
42, 1900; (d) Schrock, R. R.; Hoveyda, A. H. Angew.
Chem., Int. Ed. 2003, 42, 4592; (e) Schrock, R. R.
Tetrahedron 1999, 55, 8141; (f) Trunka, T. M.; Grubbs,
R. H. Acc. Chem. Res. 2001, 34, 18–29; (g) Hoveyda, A.
H.; Schrock, R. R. Chem. Eur. J. 2001, 7, 945; (h) Pandit,
€
U. K.; Overkleeft, H. S.; Borer, B. C.; Bieraugel, H. Eur. J.
Org. Chem. 1999, 959; (i) Maier, M. E. Angew. Chem., Int.
Ed. 2000, 39, 2073.
9. For recent reviews on enyne RCM and related recent
papers, see: (a) Poulsen, C. S.; Madsen, R. Synthesis 2003,
1; (b) Mori, M. Top Organomet. Chem. 1998, 1, 133; (c)
Kotha, S.; Sreenivasachary, N. Chem. Commun. 2000, 503;
(d) Bentz, D.; Laschat, S. Synthesis 2000, 1766; (e)
Renaud, J.; Graf, C.-D.; Oberer, L. Angew. Chem., Int.
Ed. 2000, 39, 3101; (f) Rosillo, M.; Casarrubios, L.;
Acknowledgements
This work was supported by a grant from the Korea
Research Foundation (KRF-2003-015-C00360).
References and notes
ꢁ
ꢁ
Domınguez, G.; Perez-Castells, J. Tetrahedron Lett. 2001,
42, 7029; (g) Kotha, S.; Sreenivasachary, N.; Brahma-
chary, E. Eur. J. Org. Chem. 2001, 787; (h) Saito, N.; Sato,
Y.; Mori, M. Org. Lett. 2002, 4, 803.
1. Horton, R. W.; Collins, J. F.; Anlezark, G. M.; Meldrum,
B. S. Eur. J. Pharmacol. 1979, 59, 75.
2. (a) Fehr, T.; Oberer, L.; Quesniaux Ryffel, V.; Sanglier,
J.-J.; Schuler, W.; Sedrani, R. Sandoz Ltd, PCT Int. Appl.
WO 9702285A/970123, 1997; (b) Sanglier, J.-J.; Quesni-
aux, V.; Fehr, T.; Hofmann, H.; Mahnke, M.; Memmert,
K.; Schuler, W.; Zenke, G.; Gschwind, L.; Maurer, C.;
Schilling, W. J. Antibiot. 1999, 52, 466; (c) Nicolaou, K.
10. (a) Tae, J.; Yang, Y.-K. Org. Lett. 2003, 5, 741; (b) Yang,
Y.-K.; Tae, J. Synlett 2003, 1043; (c) Yang, Y.-K.; Tae, J.
Synlett 2003, 2017.
11. The first alkylation sites were the nitrogens protected by
Cbz, which was confirmed by comparisons of the 1H